Logo

genome interpretation

Nostos Genomics Aims to Ease Variant Interpretation Bottlenecks With AI
Premium

The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes.

Euformatics Expands Latin American Presence With A&C Group Distribution Deal

The deal with A&C Group gives Euformatics a foothold in Bolivia, Peru, and Paraguay, building on an earlier partnership in Brazil.

Euformatics Signs Distribution Deal With Saudi Arabia's Al-Jeel

Riyadh-based Al-Jeel Medical and Trading Co. is augmenting its NGS partnership with Illumina by adding Euformatics analytics software to its portfolio.

Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Premium

Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.

Congenica Strikes Asian Distribution Deal With Camtech Diagnostics

Camtech will market and sell Congenica's core clinical decision support platform in Singapore, Malaysia, Japan, and South Korea.

Apr 12, 2021

Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

Apr 6, 2021

Euformatics Eyes Global Expansion in NGS Informatics
Premium

Mar 26, 2021

Rare Disease Screening Firm 3billion Closes $13M Series C Financing

Mar 18, 2021

Euformatics Partners With Síntese Biotecnologia to Enter Latin American Market

Feb 23, 2021

BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research

Feb 19, 2021

Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach

Feb 2, 2021

Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing

Dec 16, 2020

Illumina, Emedgene Partner on Automated Genomic Data Interpretation

Nov 13, 2020

With $50M in New Funding, Congenica Works on Platform Upgrades for Clinical Applications
Premium

Oct 27, 2020

OmniTier Introduces Appliance for Tertiary Next-Generation Sequencing Analysis
Premium

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

Oct 12, 2020

Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics

May 7, 2020

Informatics Startup Breakthrough Genomics Developing Coronavirus Susceptibility Assessment
Premium

May 5, 2020

PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market

Mar 13, 2020

Tempus Closes $100M Series G Round

Feb 27, 2020

Sophia Genetics to Provide Access to Genomic Analysis Platform to MGI Customers

Feb 6, 2020

Dante Labs Taps BC Platforms for Informatics Support as NGS Testing Ramps Up
Premium

Dec 20, 2019

Euformatics Picks Alliance Global as Middle Eastern Distributor

Nov 25, 2019

Primary Care Professionals May Be Able to Step in to Interpret Genetic Testing Results

Sep 18, 2019

GenomSys Raises CHF 9.3M in Series A Round

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.